The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel

<p>Abstract</p> <p>Background</p> <p>Paediatric drug formulations for artemisinin combination therapy (P-ACT) have been developed over the past few years and have been shown to improve the therapeutic management of young children with uncomplicated falciparum malaria. T...

Full description

Bibliographic Details
Main Authors: Agnandji Selidji T, Kurth Florian, Fernandes Jose F, Soulanoudjingar Solange S, Abossolo Beatrice P, Mombo-Ngoma Ghyslain, Basra Arti, González Raquel, Kizito Gondo, Mayengue Pembe I, Auer-Hackenberg Lorenz, Issifou Saadou, Lell Bertrand, Adegnika Ayola A, Ramharter Michael
Format: Article
Language:English
Published: BMC 2011-12-01
Series:Malaria Journal
Subjects:
Online Access:http://www.malariajournal.com/content/10/1/365
_version_ 1818918011190378496
author Agnandji Selidji T
Kurth Florian
Fernandes Jose F
Soulanoudjingar Solange S
Abossolo Beatrice P
Mombo-Ngoma Ghyslain
Basra Arti
González Raquel
Kizito Gondo
Mayengue Pembe I
Auer-Hackenberg Lorenz
Issifou Saadou
Lell Bertrand
Adegnika Ayola A
Ramharter Michael
author_facet Agnandji Selidji T
Kurth Florian
Fernandes Jose F
Soulanoudjingar Solange S
Abossolo Beatrice P
Mombo-Ngoma Ghyslain
Basra Arti
González Raquel
Kizito Gondo
Mayengue Pembe I
Auer-Hackenberg Lorenz
Issifou Saadou
Lell Bertrand
Adegnika Ayola A
Ramharter Michael
author_sort Agnandji Selidji T
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Paediatric drug formulations for artemisinin combination therapy (P-ACT) have been developed over the past few years and have been shown to improve the therapeutic management of young children with uncomplicated falciparum malaria. This process was however not equally paralleled by a timely adoption of P-ACT in national and international treatment recommendations. National malaria programmes in sub-Saharan Africa have not yet widely embraced this new therapeutic tool. To which extent P-ACT is used in the field in sub-Saharan Africa is not known to date.</p> <p>Methods</p> <p>This snapshot questionnaire survey aimed to provide an overview on the current routine practices for the availability and use of P-ACT as anti-malarial treatment for young children in sub-Saharan Africa. Health care personnel in seven countries in West-, Central, and East-Africa were invited to answer a structured questionnaire assessing use and availability of P-ACT.</p> <p>Results</p> <p>A total of 71 respondents including doctors, nurses and pharmacy personnel responsible for the anti-malarial treatment of young children were interviewed. P-ACT was used by 83% (95% confidence interval: 73-90%; n = 59) as first-line treatment for young children. Use of 15 different P-ACT products was reported among which only two have received WHO prequalification status and approval by a stringent registration authority. Use of a specific P-ACT product was not linked to consumer prices or availability of supporting clinical trial data, but may depend more on the marketing capacity of the manufacturer. Major differences in frequency and dosing of anti-malarial regimens with identical anti-malarial compounds and the marketing of loose combinations were recorded.</p> <p>Conclusion</p> <p>Paediatric ACT is widely used for the treatment of uncomplicated malaria in young children. However, the majority of P-ACT formulations in use do not meet highest international quality standards evoking concerns for patients' safety and the induction of drug resistance. Improving the quality of currently marketed P-ACT should constitute a public health priority besides their adoption into official treatment recommendations.</p>
first_indexed 2024-12-20T00:43:10Z
format Article
id doaj.art-177617cdcd614c748dcf489432c1f7f3
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-12-20T00:43:10Z
publishDate 2011-12-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-177617cdcd614c748dcf489432c1f7f32022-12-21T19:59:29ZengBMCMalaria Journal1475-28752011-12-0110136510.1186/1475-2875-10-365The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnelAgnandji Selidji TKurth FlorianFernandes Jose FSoulanoudjingar Solange SAbossolo Beatrice PMombo-Ngoma GhyslainBasra ArtiGonzález RaquelKizito GondoMayengue Pembe IAuer-Hackenberg LorenzIssifou SaadouLell BertrandAdegnika Ayola ARamharter Michael<p>Abstract</p> <p>Background</p> <p>Paediatric drug formulations for artemisinin combination therapy (P-ACT) have been developed over the past few years and have been shown to improve the therapeutic management of young children with uncomplicated falciparum malaria. This process was however not equally paralleled by a timely adoption of P-ACT in national and international treatment recommendations. National malaria programmes in sub-Saharan Africa have not yet widely embraced this new therapeutic tool. To which extent P-ACT is used in the field in sub-Saharan Africa is not known to date.</p> <p>Methods</p> <p>This snapshot questionnaire survey aimed to provide an overview on the current routine practices for the availability and use of P-ACT as anti-malarial treatment for young children in sub-Saharan Africa. Health care personnel in seven countries in West-, Central, and East-Africa were invited to answer a structured questionnaire assessing use and availability of P-ACT.</p> <p>Results</p> <p>A total of 71 respondents including doctors, nurses and pharmacy personnel responsible for the anti-malarial treatment of young children were interviewed. P-ACT was used by 83% (95% confidence interval: 73-90%; n = 59) as first-line treatment for young children. Use of 15 different P-ACT products was reported among which only two have received WHO prequalification status and approval by a stringent registration authority. Use of a specific P-ACT product was not linked to consumer prices or availability of supporting clinical trial data, but may depend more on the marketing capacity of the manufacturer. Major differences in frequency and dosing of anti-malarial regimens with identical anti-malarial compounds and the marketing of loose combinations were recorded.</p> <p>Conclusion</p> <p>Paediatric ACT is widely used for the treatment of uncomplicated malaria in young children. However, the majority of P-ACT formulations in use do not meet highest international quality standards evoking concerns for patients' safety and the induction of drug resistance. Improving the quality of currently marketed P-ACT should constitute a public health priority besides their adoption into official treatment recommendations.</p>http://www.malariajournal.com/content/10/1/365Artemisinin based combinations therapyPaediatric drug formulationArtemetherLumefantrineAmodiaquineDihydroartemisininPiperaquineMefloquine
spellingShingle Agnandji Selidji T
Kurth Florian
Fernandes Jose F
Soulanoudjingar Solange S
Abossolo Beatrice P
Mombo-Ngoma Ghyslain
Basra Arti
González Raquel
Kizito Gondo
Mayengue Pembe I
Auer-Hackenberg Lorenz
Issifou Saadou
Lell Bertrand
Adegnika Ayola A
Ramharter Michael
The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
Malaria Journal
Artemisinin based combinations therapy
Paediatric drug formulation
Artemether
Lumefantrine
Amodiaquine
Dihydroartemisinin
Piperaquine
Mefloquine
title The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
title_full The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
title_fullStr The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
title_full_unstemmed The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
title_short The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
title_sort use of paediatric artemisinin combinations in sub saharan africa a snapshot questionnaire survey of health care personnel
topic Artemisinin based combinations therapy
Paediatric drug formulation
Artemether
Lumefantrine
Amodiaquine
Dihydroartemisinin
Piperaquine
Mefloquine
url http://www.malariajournal.com/content/10/1/365
work_keys_str_mv AT agnandjiselidjit theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT kurthflorian theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT fernandesjosef theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT soulanoudjingarsolanges theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT abossolobeatricep theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT mombongomaghyslain theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT basraarti theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT gonzalezraquel theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT kizitogondo theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT mayenguepembei theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT auerhackenberglorenz theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT issifousaadou theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT lellbertrand theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT adegnikaayolaa theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT ramhartermichael theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT agnandjiselidjit useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT kurthflorian useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT fernandesjosef useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT soulanoudjingarsolanges useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT abossolobeatricep useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT mombongomaghyslain useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT basraarti useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT gonzalezraquel useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT kizitogondo useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT mayenguepembei useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT auerhackenberglorenz useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT issifousaadou useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT lellbertrand useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT adegnikaayolaa useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel
AT ramhartermichael useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel